mycophenolate mofetil clonmel 500 mg film-coated tablets
clonmel healthcare ltd - mycophenolate mofetil - film-coated tablet - 500 milligram(s) - selective immunosuppressants; mycophenolic acid
cellcept for i.v. infusion 500 mgvial
roche singapore pte. ltd. - mycophenolate mofetil - injection, powder, for solution - 500 mg/vial - mycophenolate mofetil 500 mg/vial
cellcept tablet 500 mg
roche singapore pte. ltd. - mycophenolate mofetil - tablet, film coated - 500 mg - mycophenolate mofetil 500 mg
cellcept capsule 250 mg
roche singapore pte. ltd. - mycophenolate mofetil - capsule - 250 mg - mycophenolate mofetil 250 mg
mycophenolate mofetil 500mg film-coated tablets
accord healthcare limited - mycophenolate mofetil - film-coated tablet - mycophenolate mofetil 500 mg - immunosuppressants
mycophenolate mofetil 250mg capsules
accord healthcare limited - mycophenolate mofetil - hard capsule - mycophenolate mofetil 250 mg - immunosuppressants
cellcept
roche registration gmbh - mycophenolate mofetil - graft rejection - immunosuppressants - cellcept is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
myclausen
passauer pharma gmbh - mycophenolate mofetil - graft rejection - immunosuppressants - myclausen is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.,
mycophenolate mofetil teva
teva pharma b.v. - mycophenolate mofetil - graft rejection - immunosuppressants - mycophenolate mofetil teva is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
myfenax
teva b.v. - mycophenolate mofetil - graft rejection - immunosuppressants - myfenax is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.